Document is current
Any future updates will be listed below
-
Authors
Uwimana, Aline
Robert, Annie
Ahmed, Ayman
Alexiou, Hélène
Rujeni, Nadine
Cani, Patrice D.
Coutelier, Jean-Paul
Mutesa, Léon
Everard, Amandine
-
Funding
Funding for this research was provided by:
Académie de Recherche et d’Enseignement Supérieur
Walloon excellence in life sciences and biotechnology (WELBIO-CR-2022A-02P, WELBIO-CR-2019S-03R)
Fonds De La Recherche Scientifique - FNRS (EOS: program no. 40007505, J.0075.22)
- License Information
-
More Information
Article History
Received: 7 October 2024
Accepted: 10 April 2025
First Online: 13 May 2025
Declarations
:
: Data was extracted from Rwanda’s Demographical Health Survey (DHS), which is publicly available at , after receiving written approval to use it from Macro.
: A.E. and P.D.C. are inventors on patent applications dealing with the use of A. muciniphila and its components in the treatment of metabolic disorders. A. E. and P.D.C. are inventors on patent applications dealing with gut microbes in food reward dysregulations. A.E. is inventor on patent applications dealing with the use of bacteria metabolites in the prevention or treatment of respiratory viral infections P.D.C. was cofounder of The Akkermansia company SA and Enterosys. All other authors declare they have no competing interests.
